hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and differentiation programs in hematologic malignancies

A new mathematical model for relative quantification in real-time RT-PCR

Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · see citing works

Acute-Phase Proteins and Other Systemic Responses to Inflammation

Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · see citing works

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078 · see citing works

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542 · see citing works

Hematopoietic stem cell: self‐renewal versus differentiation

Seita, J., & Weissman, I. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.86 · Cited by 925 · see citing works

Therapeutic Advances in Acute Myeloid Leukemia

Burnett, A. K., Wetzler, M., & Löwenberg, B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1820 · Cited by 786 · see citing works

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Mrózek, K., Marcucci, G., Paschka, P., Whitman, S. P., & Bloomfield, C. D. (2006) · Blood · doi:10.1182/blood-2006-06-001149 · Cited by 544 · see citing works

mRNA Silencing in Erythroid Differentiation: hnRNP K and hnRNP E1 Regulate 15-Lipoxygenase Translation from the 3′ End

Ostareck, D. H., Ostareck‐Lederer, A., Wilm, M. S., Thiele, B. J., Mann, M., & Hentze, M. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80241-x · Cited by 502 · see citing works

Cooperating gene mutations in acute myeloid leukemia: a review of the literature

Renneville, A., Roumier, C., Biggio, V., Nibourel, O., Boissel, N., Fenaux, P., & Preudhomme, C. (2008) · Leukemia · doi:10.1038/leu.2008.19 · Cited by 348 · see citing works

Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance

Quintás‐Cardama, A., & Verstovšek, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0284 · Cited by 284 · see citing works

C/EBPα mutations in acute myeloid leukaemias

Nerlov, C. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1363 · Cited by 277 · see citing works

Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia

Krönke, J., Bullinger, L., Teleanu, V., Tschürtz, F., Gaidzik, V. I., Kühn, M. W. M., Rücker, F. G., Holzmann, K., Paschka, P., Kapp‐Schwoerer, S., et al. (2013) · Blood · doi:10.1182/blood-2013-01-479188 · Cited by 272 · see citing works

Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells

Kirstetter, P., Schuster, M. B., Bereshchenko, O., Moore, S., Dvinge, H., Kurz, E., Theilgaard-Mönch, K., Månsson, R., Pedersen, T. Å., Pabst, T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.008 · Cited by 251 · see citing works

c-Src-Mediated Phosphorylation of hnRNP K Drives Translational Activation of Specifically Silenced mRNAs

Ostareck‐Lederer, A., Ostareck, D. H., Cans, C., Neubauer, G., Bomsztyk, K., Superti‐Furga, G., & Hentze, M. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4535-4543.2002 · Cited by 222 · see citing works

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation

Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D., Caligiuri, M. A., Marcucci, G., et al. (2005) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202 · see citing works

Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress

Bochkis, I. M., Rubins, N. E., White, P., Furth, E. E., Friedman, J. R., & Kaestner, K. H. (2008) · Nature Medicine · doi:10.1038/nm.1853 · Cited by 186 · see citing works

MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53

Enge, M., Bao, W., Hedström, E., Jackson, S. P., Moumen, A., & Selivanova, G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.019 · Cited by 170 · see citing works

A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development

Post, S. M., Quintás-Cardama, A., Pant, V., Iwakuma, T., Hamir, A., Jackson, J. G., Maccio, D. R., Bond, G. L., Johnson, D. G., Levine, A. J., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.010 · Cited by 127 · see citing works

hnRNP K Binds a Core Polypyrimidine Element in the Eukaryotic Translation Initiation Factor 4E (eIF4E) Promoter, and Its Regulation of eIF4E Contributes to Neoplastic Transformation

Lynch, M. C., Chen, L., Ravitz, M. J., Mehtani, S., Korenblat, K., Pazin, M. J., & Schmidt, E. V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6436-6453.2005 · Cited by 126 · see citing works

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Huang, X., Meng, B., Iqbal, J., Ding, B. B., Perry, A. M., Cao, W., Smith, L. M., Bi, C., Jiang, C., Greiner, T. C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.6004 · Cited by 122 · see citing works

Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival

Dayyani, F., Wang, J., Yeh, J.-R. J., Ahn, E.-Y. E., Tobey, E. M., Zhang, D., Bernstein, I. D., Peterson, R. T., & Sweetser, D. A. (2008) · Blood · doi:10.1182/blood-2007-07-103291 · Cited by 91 · see citing works

Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma

Matta, A., Tripathi, S. C., DeSouza, L. V., Grigull, J., Kaur, J., Chauhan, S. S., Srivastava, A., Thakar, A., Shukla, N. K., Duggal, R., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24517 · Cited by 71 · see citing works

Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53

Zhou, R., Shañas, R., Nelson, M. A., Bhattacharyya, A. K., & Shi, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24744 · Cited by 65 · see citing works

Identification of Heterogeneous Nuclear Ribonucleoprotein K (hnRNP K) as a Repressor of C/EBPβ-mediated Gene Activation

Miau, L.-H., Chang, C., Shen, B.-J., Tsai, W.-H., & Lee, S.-C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10784 · Cited by 65 · see citing works

Effects of Age on the Posttranscriptional Regulation of CCAAT/Enhancer Binding Protein α and CCAAT/Enhancer Binding Protein β Isoform Synthesis in Control and LPS-Treated Livers

Hsieh, C.-C., Xiong, W., Xie, Q., Rabek, J. P., Scott, S. G., An, M. R., Reisner, P. D., Kuninger, D., & Papaconstantinou, J. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.6.1479 · Cited by 63 · see citing works

Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemia

Sweetser, D. A., Peniket, A. J., Haaland, C. M., Blomberg, A. A., Zhang, Y., Zaidi, S. T., Dayyani, F., Zheng, Z. S., Heerema, N. A., Boultwood, J., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20236 · Cited by 59 · see citing works

hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed for axonogenesis

Liu, Y., & Szaro, B. G. (2011) · Development · doi:10.1242/dev.066993 · Cited by 59 · see citing works

Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma

Roychoudhury, P., & Chaudhuri, K. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603911 · Cited by 39 · see citing works

Interstitial 9q—Deletions in hematologic malignancies

Mecucci, C., Vermaelen, K., Kulling, G., Michaux, J., Noens, L. A., Hove, W. V., Tricot, G. J. K., Louwagie, A. C., & BERGHE, H. V. D. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90064-5 · Cited by 37 · see citing works

Heterogeneous Nuclear Ribonucleoprotein (HnRNP) K Genome-wide Binding Survey Reveals Its Role in Regulating 3′-End RNA Processing and Transcription Termination at the Early Growth Response 1 (EGR1) Gene through XRN2 Exonuclease*

Mikuła, M., Bomsztyk, K., Goryca, K., Chojnowski, K., & Ostrowski, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496679 · Cited by 36 · see citing works

Protein Kinase C-δ mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction

Gao, F., Wu, Y., Zhao, M. L., Liu, C., Wang, L., & Chen, G. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.005 · Cited by 34 · see citing works

Precision Mechanics with Multifunctional Tools: How HnRNP K and HnRNPs E1/E2 Contribute to Post-Transcriptional Control of Gene Expression in Hematopoiesis

Ostareck‐Lederer, A., & Ostareck, D. H. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312801619484 · Cited by 33 · see citing works

All Human Granzymes Target hnRNP K That Is Essential for Tumor Cell Viability

van Domselaar, R., Quadir, R., van der Made, A. M., Broekhuizen, R., & Bovenschen, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365692 · Cited by 31 · see citing works

Hnrnpk, a Protein Differentially Expressed in Immature Rat Ovarian Development, Is Required for Normal Primordial Follicle Assembly and Development

Wang, N., Zhang, P., Guo, X., Zhou, Z., & Sha, J. (2010) · Endocrinology · doi:10.1210/en.2010-0797 · Cited by 18 · see citing works

Lack of the p42 form of C/EBPα leads to spontaneous immortalization and lineage infidelity of committed myeloid progenitors

Schuster, M. B., Frank, A.-K., Bagger, F. O., Rapin, N., Vikesaa, J., & Porse, B. T. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.06.003 · Cited by 9 · see citing works

The hnRNP family: insights into their role in health and disease

Geuens, T., Bouhy, D., & Timmerman, V. (2016) · Human Genetics · doi:10.1007/s00439-016-1683-5 · Cited by 1,096 · see citing works

RNA-Binding Proteins in Cancer: Old Players and New Actors

Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 765 · see citing works

RNA splicing factors as oncoproteins and tumour suppressors

Dvinge, H., Kim, E. H., Abdel-Wahab, O. I., & Bradley, R. K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.51 · Cited by 684 · see citing works

RNA splicing dysregulation and the hallmarks of cancer

Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579 · see citing works

Alternative splicing and cancer: a systematic review

Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 525 · see citing works

Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics

Urbanski, L. M., Leclair, N. K., & Anczuków, O. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1476 · Cited by 381 · see citing works

Splicing-factor alterations in cancers

Anczuków, O., & Krainer, A. R. (2016) · RNA · doi:10.1261/rna.057919.116 · Cited by 297 · see citing works

Alternative mRNA splicing in cancer immunotherapy

Frankiw, L., Baltimore, D., & Li, G. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0195-7 · Cited by 248 · see citing works

The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer

Marabti, E. E., & Younis, I. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00080 · Cited by 217 · see citing works

RNA Splicing and Disease: Animal Models to Therapies

Montes, M., Sanford, B. L., Comiskey, D. F., & Chandler, D. S. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.10.002 · Cited by 214 · see citing works

RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia

Cheng, J. X., Chen, L., Li, Y., Cloe, A., Yue, M., Wei, J., Watanabe, K. A., Shammo, J. M., Anastasi, J., Shen, Q. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03513-4 · Cited by 204 · see citing works

Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer

Mohibi, S., Chen, X., & Zhang, J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.001 · Cited by 205 · see citing works

The emerging roles of hnRNPK

Wang, Z.-Y., Qiu, H., He, J.-B., Liu, L.-X., Xue, W., Fox, A. H., Tickner, J. C., & Xu, J.-K. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29186 · Cited by 143 · see citing works

Xist Deletional Analysis Reveals an Interdependency between Xist RNA and Polycomb Complexes for Spreading along the Inactive X

Colognori, D., Sunwoo, H., Kriz, A. J., Wang, C., & Lee, J. T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.015 · Cited by 168 · see citing works

Novel players in X inactivation: insights into Xist-mediated gene silencing and chromosome conformation

da Rocha, S. T., & Heard, É. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3370 · Cited by 134 · see citing works

The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription

Xia, A., Yuan, W., Wang, Q., Xu, J., Gu, Y., Zhang, L., Chen, C., Wang, Z., Wu, D., He, Q., et al. (2022) · Nature Cancer · doi:10.1038/s43018-021-00315-4 · Cited by 125 · see citing works

Aberrant hnRNP K expression: All roads lead to cancer

Gallardo, M., Aitken, M. J. L., Zhang, X., Hu, P. C., Bueso-Ramos, C., & Post, S. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1164372 · Cited by 107 · see citing works

Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics

Qiu, P., Zhou, Y., Oyang, L., Wu, N., Tang, Y., Su, M., Luo, X., Wang, Y., Sheng, X., Ma, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.010 · Cited by 103 · see citing works

MYC protein expression is an important prognostic factor in acute myeloid leukemia

Ohanian, M. N., Rozovski, U., Kanagal‐Shamanna, R., Abruzzo, L. V., Loghavi, S., Kadia, T. M., Futreal, P. A., Bhalla, K. N., Zuo, Z., Huh, Y. O., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1464158 · Cited by 95 · see citing works

PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK

Zhu, L., Tian, Q., Gao, H., Wu, K., Wang, B., Ge, G., Jiang, S., Wang, K., Zhou, C., He, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68960 · Cited by 78 · see citing works

Targeting splicing abnormalities in cancer

Agrawal, A. A., Yu, L., Smith, P. G., & Buonamici, S. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.010 · Cited by 75 · see citing works

Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides

Torres, A. N. B., Cats, D., Mei, H., Szuhai, K., Willemze, R., Vermeer, M. H., & Tensen, C. P. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22679 · Cited by 73 · see citing works

LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?

Taìana, E., Ronchetti, D., Todoerti, K., Nobili, L., Tassone, P., Amodio, N., & Neri, A. (2020) · Non-Coding RNA · doi:10.3390/ncrna6030026 · Cited by 70 · see citing works

The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data

Muelas, M. W., Mughal, F., O’Hagan, S., Day, P. J., & Kell, D. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54288-7 · Cited by 65 · see citing works

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

Alanazi, B., Munje, C. R., Rastogi, N., Williamson, A. J. K., Taylor, S., Hole, P. S., Hodges, M., Doyle, M., Baker, S., Gilkes, A. F., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0596-4 · Cited by 64 · see citing works

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer

Cerasuolo, A., Buonaguro, L., Buonaguro, L., & Tornesello, M. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00474 · Cited by 66 · see citing works

LINC01413/hnRNP-K/ZEB1 Axis Accelerates Cell Proliferation and EMT in Colorectal Cancer via Inducing YAP1/TAZ1 Translocation

Ji, L., Li, X., Zhou, Z., Zheng, Z., Jin, L., & Jiang, F. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.027 · Cited by 60 · see citing works

RNA-Binding Proteins in Acute Leukemias

Schuschel, K., Helwig, M., Hüttelmaier, S., Heckl, D., Klusmann, J., & Hoell, J. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103409 · Cited by 57 · see citing works

HNRNPK maintains epidermal progenitor function through transcription of proliferation genes and degrading differentiation promoting mRNAs

Li, J., Chen, Y., Xu, X., Jones, J., Tiwari, M., Ling, J., Wang, Y., Harismendy, O., & Sen, G. L. (2019) · Nature Communications · doi:10.1038/s41467-019-12238-x · Cited by 55 · see citing works

LCDR regulates the integrity of lysosomal membrane by hnRNP K–stabilized LAPTM5 transcript and promotes cell survival

Yang, X., Wen, Y., Liu, S., Duan, L., Liu, T., Tong, Z., Wang, Z., Gu, Y., Xi, Y., Wang, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110428119 · Cited by 53 · see citing works

Allelic imbalance of somatic mutations in cancer genomes and transcriptomes

Rhee, J., Lee, S., Park, W., Kim, Y.-H., & Kim, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-01966-z · Cited by 47 · see citing works

hnRNPK recognition of the B motif of Xist and other biological RNAs

Nakamoto, M. Y., Lammer, N. C., Batey, R., & Wuttke, D. S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa677 · Cited by 46 · see citing works

Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice

Liu, T.-Y., Chen, Y., Jong, Y., Tsai, H., Lee, C., Chang, Y., Chang, J.-G., & Chang, Y.-F. (2017) · Open Biology · doi:10.1098/rsob.160303 · Cited by 45 · see citing works

hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing

Peng, W.-Z., Liu, J.-X., Li, C., Ma, R., & Jie, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1020-x · Cited by 45 · see citing works

Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets

Wang, Y., Bao, Y., Zhang, S., & Wang, Z. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1605-0 · Cited by 44 · see citing works

Phenotypic spectrum of Au–Kline syndrome: a report of six new cases and review of the literature

Au, P. Y. B., Goedhart, C., Ferguson, M., Breckpot, J., Devriendt, K., Wierenga, K. J., Fanning, E., Grange, D. K., Graham, G. E., Galarreta, C. I., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0187-2 · Cited by 41 · see citing works

Harnessing host–virus evolution in antiviral therapy and immunotherapy

Heaton, S. M. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1067 · Cited by 41 · see citing works

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer

Kitamura, K., & Nimura, K. (2021) · Cells · doi:10.3390/cells10040923 · Cited by 38 · see citing works

Comprehensive network of miRNA-induced intergenic interactions and a biological role of its core in cancer

Galatenko, V., Galatenko, A. V., Samatov, T. R., Turchinovich, A. A., Shkurnikov, M. Y., Makarova, J. A., & Tonevitsky, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-20215-5 · Cited by 36 · see citing works

Induction of Senescence in Cancer Cells by a Novel Combination of Cucurbitacin B and Withanone: Molecular Mechanism and Therapeutic Potential

Garg, S., Huifu, H., Kumari, A., Sundar, D., Kaul, S. C., & Wadhwa, R. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz077 · Cited by 38 · see citing works

Cancer‐associated mutations in VAV1 trigger variegated signaling outputs and T‐cell lymphomagenesis

Robles‐Valero, J., Fernández‐Nevado, L., Lorenzo‐Martín, L. F., Cuadrado, M., Fernández‐Pisonero, I., Rodríguez‐Fdez, S., Astorga‐Simón, E. N., Abad, A., Caloto, R., & Bustelo, X. R. (2021) · The EMBO Journal · doi:10.15252/embj.2021108125 · Cited by 36 · see citing works

SKI controls MDS-associated chronic TGF-β signaling, aberrant splicing, and stem cell fitness

Muench, D. E., Ferchen, K., Velu, C. S., Pradhan, K., Chetal, K., Chen, X., Weirauch, M. T., Colmenares, C., Verma, A. K., Salomonis, N., et al. (2018) · Blood · doi:10.1182/blood-2018-06-860890 · Cited by 35 · see citing works

Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas

Gallardo, M., Malaney, P., Aitken, M. J. L., Zhang, X., Link, T. M., Shah, V. V., Alybayev, S., Wu, M., Pageon, L. R., Ma, H., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz078 · Cited by 36 · see citing works

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia

Post, S. M., Ma, H., Malaney, P., Zhang, X., Aitken, M. J. L., Mak, P. Y., Ruvolo, V. R., Yasuhiro, T., Kozaki, R., Chan, L. E., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278369 · Cited by 33 · see citing works

Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape

Sudhakaran, M., & Doseff, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065086 · Cited by 30 · see citing works

HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway

Huang, H., Han, Y. K., Yang, X., Li, M., Zhu, R., Hu, J., Zhang, X., Wei, R., Li, K., & Gao, R. (2017) · Oncotarget · doi:10.18632/oncotarget.21873 · Cited by 30 · see citing works

FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis

Wu, L., Zhu, X., Song, Z., Guo, M., Liang, J., & Yan, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117998 · Cited by 29 · see citing works

Regulation of HNRNP family by post-translational modifications in cancer

Li, B., Wen, M., Gao, F., Wang, Y., Wei, G., & Duan, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02198-7 · Cited by 28 · see citing works

A biophysical basis for the spreading behavior and limited diffusion of Xist

Ding, M., Wang, D., Chen, H., Kesner, B., Grimm, N.-B., Weissbein, U., Lappala, A., Jiang, J., Rivera, C., Lou, J., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.004 · Cited by 29 · see citing works

KH-Domain Poly(C)-Binding Proteins as Versatile Regulators of Multiple Biological Processes

Nazarov, I. B., Bakhmet, E. I., & Tomilin, A. N. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919030039 · Cited by 27 · see citing works

A tumor-specific modulation of heterogeneous ribonucleoprotein A0 promotes excessive mitosis and growth in colorectal cancer cells

Konishi, H., Fujiya, M., Kashima, S., Sakatani, A., Dokoshi, T., Ando, K., Ueno, N., Iwama, T., Moriichi, K., Tanaka, H., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2439-7 · Cited by 28 · see citing works

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia

Liu, M., Yang, L., Liu, X., Nie, Z.-Y., Zhang, X., Lu, Y., Pan, Y., Wang, X., & Luo, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682859 · Cited by 27 · see citing works

Deletion of Hnrnpk Gene Causes Infertility in Male Mice by Disrupting Spermatogenesis

Xu, H., Guo, J., Wu, W., Qiu, H., Huang, Y., Wang, Y., Li, C., Cheng, X., Zhang, P., & Xu, Y. (2022) · Cells · doi:10.3390/cells11081277 · Cited by 27 · see citing works

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction

Li, Y., Yang, Y., Ma, Q., Cheng, H., Wang, H., Ma, C., Li, F., Zhao, S., Li, X., Qi, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.76083 · Cited by 26 · see citing works

The multifunctional RNA-binding protein hnRNPK is critical for the proliferation and differentiation of myoblasts

Xu, Y., Li, R., Zhang, K., Wu, W., Wang, S., Zhang, P., & Xu, H. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.7.043 · Cited by 25 · see citing works

Whole‐genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm

Torres, A. N. B., Cats, D., Mei, H., Fanoni, D., Gliozzo, J., Corti, L., Paulli, M., Vermeer, M. H., Willemze, R., Berti, E., et al. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22831 · Cited by 24 · see citing works

Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation

Mucha, B., Qie, S., Bajpai, S., Tarallo, V., Diehl, J. N., Tedeschi, F., Zhou, G., Gao, Z., Flashner, S., Klein-Szanto, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34402-6 · Cited by 23 · see citing works

Post-transcriptional regulation in hematopoiesis: RNA binding proteins take control

de Rooij, L. P. M. H., Chan, D. C. H., Chahi, A. K., & Hope, K. J. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0310 · Cited by 23 · see citing works

Connecting Versatile lncRNAs with Heterogeneous Nuclear Ribonucleoprotein K and Pathogenic Disorders

Zhu, S., Wang, Z., & Xu, J. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.06.001 · Cited by 23 · see citing works

The B-side of Xist

Monfort, A., & Wutz, A. (2020) · F1000Research · doi:10.12688/f1000research.21362.1 · Cited by 20 · see citing works

Introduction to Epigenetics

Paro, R., Grossniklaus, U., Santoro, R., & Wutz, A. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-68670-3 · Cited by 21 · see citing works

The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma

Li, Y., Wang, H., Wan, J., Ma, Q., Qi, Y., & Gu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.845931 · Cited by 20 · see citing works

Comprehensive Analysis of the Functions and Prognostic Value of RNA-Binding Proteins in Thyroid Cancer

Ma, Y., Yin, S., Liu, X., Hu, J. R., Cai, N., Zhang, X.-B., Fu, L., Cao, X., & Yu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.625007 · Cited by 19 · see citing works

Characterization of acute myeloid leukemia with del(9q) – Impact of the genes in the minimally deleted region

Vries, I. S. N., Sackmann, Y., Klein, F., Ostareck‐Lederer, A., Ostareck, D. H., Jost, E., Ehninger, G., Brümmendorf, T. H., Marx, G., Röllig, C., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.11.007 · Cited by 19 · see citing works

hnRNP-K Targets Open Chromatin in Mouse Embryonic Stem Cells in Concert with Multiple Regulators

Bakhmet, E. I., Nazarov, I. B., Gazizova, A. R., Vorobyeva, N. E., Kuzmin, A. A., Gordeev, M. N., Sinenko, S. A., Aksenov, N. D., Артамонова, Т. О., Khodorkovskii, M. A., et al. (2019) · Stem Cells · doi:10.1002/stem.3025 · Cited by 17 · see citing works

RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase

Yin, Z., Kobayashi, M., Hu, W., Higashi, K., Begum, N. A., Kurokawa, K., & Honjo, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921115117 · Cited by 19 · see citing works

Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias

Mäkelä, E., Pavic, K., Varila, T., Salmenniemi, U., Löyttyniemi, E., Nagelli, S. G., Ammunét, T., Kähäri, V.-M., Clark, R. E., Elo, L. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3679 · Cited by 18 · see citing works

Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

Zhao, H., Wei, Z., Shen, G., Chen, Y., Hao, X., Li, S., & Wang, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1045797 · Cited by 17 · see citing works

Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1

Li, D., Guo, J., & Jia, R. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.167993 · Cited by 17 · see citing works

From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform

Tian, N., Li, J., Shi, J., & Sui, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030191 · Cited by 17 · see citing works

Tubular Deficiency of Heterogeneous Nuclear Ribonucleoprotein F Elevates Systolic Blood Pressure and Induces Glycosuria in Mice

Lo, C., Miyata, K. N., Zhao, S., Ghosh, A., Chang, S., Chénier, I., Filep, J. G., Ingelfinger, J. R., Zhang, S., & Chan, J. S. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-52323-1 · Cited by 16 · see citing works

Role of heterogeneous nuclear ribonucleoprotein K in tumor development

Chen, Y., Zeng, Y., Xiao, Z. Y., Chen, S., Li, Y., Zou, J., & Zeng, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28867 · Cited by 16 · see citing works

The Role of RNA-Binding Proteins in Hematological Malignancies

Aguilar-Garrido, P., Otero, Á., Navarro-Aguadero, M. Á., Velasco‐Estevez, M., & Gallardo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179552 · Cited by 15 · see citing works

Peroxiredoxin 5 regulates osteogenic differentiation through interaction with hnRNPK during bone regeneration

Cho, E., Che, X., Ang, M. J., Cheon, S., Lee, J., Kim, K. S., Lee, C. H., Lee, S.-Y., Yang, H., Moon, C., et al. (2023) · eLife · doi:10.7554/elife.80122 · Cited by 13 · see citing works

The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia

Wakim, J., Arman, E., Becker-Herman, S., Kramer, M. P., Bakos, E., Shachar, I., & Elson, A. (2017) · Oncogene · doi:10.1038/onc.2016.523 · Cited by 13 · see citing works

RNA Regulators in Leukemia and LymphomaPreprint

Prieto, C., & Kharas, M. G. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034967 · Cited by 13 · see citing works

Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing

Aitken, M. J. L., Malaney, P., Zhang, X., Herbrich, S. M., Chan, L., Benitez, O., Rodriguez, A., Ma, H., Jacamo, R. O., Duan, R., et al. (2022) · NAR Cancer · doi:10.1093/narcan/zcac039 · Cited by 12 · see citing works

Downregulation of HNRNPK in human cancer cells inhibits lung metastasis

Li, M., Zhang, W., Yang, X., Liu, H., Cao, L., Li, W., Wang, L., Zhang, G., & Gao, R. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12090 · Cited by 12 · see citing works

VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles

Cuadrado, M., & Robles‐Valero, J. (2021) · Biology · doi:10.3390/biology10090888 · Cited by 12 · see citing works

p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL

Lee, H. J., Gallardo, M., Ma, H., Zhang, X., Larsson, C. A., Mejia, A., Hornbaker, M., Qi, Y., Su, X., Pageon, L. R., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.41 · Cited by 13 · see citing works

The long non-coding RNA RSDR protects against acute kidney injury in mice by interacting with hnRNPK to regulate DHODH-mediated ferroptosis

Li, B., Lin, F., Song, B., Han, S., Ye, Z., Sun, Y., Wang, P., Xia, Y., Yu, W., Zhou, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62433-2 · Cited by 11 · see citing works

Hnrnpk is essential for embryonic limb bud development as a transcription activator and a collaborator of insulator protein Ctcf

Chen, Y., Zhou, T., Liao, Z., Gao, W., Wu, J., Zhang, S., Li, Y., Liu, H., Zhou, H., Xu, C., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01207-z · Cited by 11 · see citing works

Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkers.

Dlamini, Z., Shoba, B., & Hull, R. (2020) · PubMed Central · Cited by 10 · see citing works

Chromatin Regulator SPEN/SHARP in X Inactivation and Disease

Giaimo, B. D., Robert-Finestra, T., Oswald, F., Gribnau, J. H., & Borggrefe, T. (2021) · Cancers · doi:10.3390/cancers13071665 · Cited by 10 · see citing works

Identifying novel regulators of placental development using time-series transcriptome data

Vu, H. T. H., Kaur, H., Kies, K. R., Starks, R. R., & Tuteja, G. (2022) · Life Science Alliance · doi:10.26508/lsa.202201788 · Cited by 10 · see citing works

Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology

Su, Y., Guo, Y., Guo, J., Zeng, T., Wang, T., & Liu, W. (2023) · BMC Genomics · doi:10.1186/s12864-023-09238-z · Cited by 9 · see citing works

Expression analysis of multifunctional RNA-binding protein hnRNP K during development of mammalian testis

Xu, H., Zhang, P., Li, R., Wu, W., Wang, S., & Xu, Y. (2018) · Polish Journal of Veterinary Sciences · doi:10.24425/122603 · Cited by 9 · see citing works

Odorant Sensory Input Modulates DNA Secondary Structure Formation and Heterogeneous Ribonucleoprotein Recruitment on the Tyrosine Hydroxylase and Glutamic Acid Decarboxylase 1 Promoters in the Olfactory Bulb

Wang, M., Cai, E., Fujiwara, N., Fones, L., Brown, E., Yanagawa, Y., & Cave, J. W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1363-16.2017 · Cited by 9 · see citing works

Nucleic acid-binding KH domain proteins influence a spectrum of biological pathways including as part of membrane-localized complexes

Hasan, M. K., & Brady, L. J. (2024) · Journal of Structural Biology X · doi:10.1016/j.yjsbx.2024.100106 · Cited by 8 · see citing works

hnRNPK-derived cell-penetrating peptide inhibits cancer cell survival

Pavan Kumar, P., Buczkowski, S. A., & Moon, A. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.10.004 · Cited by 8 · see citing works

Assessing the role of intrinsic disorder in RNA-binding protein function: hnRNP K as a case study

Malaney, P., Benitez, O., Zhang, X., & Post, S. M. (2022) · Methods · doi:10.1016/j.ymeth.2022.10.009 · Cited by 8 · see citing works

Removal of Nonspecific Binding Proteins is Required in Co-Immunoprecipitation with Nuclear Proteins

Zeng, X., Zeng, W.-H., Zhou, J., Liu, X., Huang, G. C., Zhu, H. M., Xiao, S., Zeng, Y., & Cao, D. (2022) · BioTechniques · doi:10.2144/btn-2022-0048 · Cited by 8 · see citing works

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Aitken, M. J. L., Bueso-Ramos, C., Abbas, H. A., Post, S. M., de Bont, E. S. J. M., & Kornblau, S. M. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800133 · Cited by 8 · see citing works

Insights into the role of hnRNPK in spermatogenesis via the piRNA pathway

Xu, H., Guo, J., Huang, Y., Zhang, M., Wang, Y., Li, X., Cheng, X., Meng, T., Hao, R., Wei, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91081-1 · Cited by 7 · see citing works

Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment

Sun, D., Zhao, X., Yu, Y., Li, W., Gu, P., Zhi, Z., & Xu, D. (2022) · Bioscience Reports · doi:10.1042/bsr20212090 · Cited by 7 · see citing works

The RNA binding protein hnRNPK protects against adriamycin-induced podocyte injury

Zhao, S., Feng, J., Li, J., Cao, R., Zhang, Y., Yang, S., & Yin, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3577 · Cited by 6 · see citing works

The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathies

Aguilar-Garrido, P., Velasco‐Estevez, M., Navarro-Aguadero, M. Á., Otero, Á., Ibáñez-Navarro, M., Marugal, M. Á., Hernández‐Sánchez, M., Malaney, P., Rodriguez, A., Benitez, O., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci183697 · Cited by 6 · see citing works

Recruitment of chromatin remodelers by XIST B-repeat region is variably dependent on HNRNPK

Navarro-Cobos, M. J., & Brown, C. J. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae173 · Cited by 6 · see citing works

Insights into the Establishment of Chromatin States in Pluripotent Cells from Studies of X Inactivation

Postlmayr, A., & Wutz, A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.013 · Cited by 6 · see citing works

Activation of NLRP2 in Triple-Negative Breast Cancer sensitizes chemotherapeutic therapy through facilitating hnRNPK function

Jin, L., Li, T., Hong, Y., Mao, R., Li, X., Zhu, C., Mu, J., Zhou, J., Pan, L., Que, Y., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115703 · Cited by 6 · see citing works

hnRNP K: A Tumor Suppressor or Oncogene?

Gallardo, M., Lee, H. J., Bueso-Ramos, C., Zhang, X., Pageon, L. R., Multani, A. S., Rapado, I., Quintás‐Cardama, A., Kornblau, S. M., Martínez‐López, J., et al. (2014) · Blood · doi:10.1182/blood.v124.21.259.259 · Cited by 1 · see citing works

hnRNP K Is a Novel Haploinsufficient Tumor Suppressor at the 9q21.32 Locus That Defines a Subset of AML

Gallardo, M., Lee, H. J., Zhang, X., Bueso-Ramos, C., Pageon, L. R., McArthur, M. J., Multani, A. S., Nazha, A., Manshouri, T., Parker‐Thornburg, J., et al. (2015) · Blood · doi:10.1182/blood.v126.23.439.439

hnRNP K Overexpression Drives AML Progression By Altering Pathways Critical for Myeloid Proliferation and Differentiation

Hornbaker, M., Gallardo, M., Zhang, X., Ma, H., Hu, P. C., Khoury, J. D., Kornblau, S. M., Bueso-Ramos, C., & Post, S. M. (2016) · Blood · doi:10.1182/blood.v128.22.744.744 · Cited by 3 · see citing works

Aberrant hnRNP K expression: All roads lead to cancer

Gallardo, M., Aitken, M. J. L., Zhang, X., Hu, P. C., Bueso-Ramos, C., & Post, S. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1164372 · Cited by 107 · see citing works

hnRNP K: A Regulator of Global Transcription and Translation That Drives Lymphomagenesis

Malaney, P., Gallardo, M., Hornbaker, M., Zhang, X., Link, T. M., Shah, V. V., Alybayev, S., Wu, M., Pageon, L. R., Ma, H., et al. (2018) · Blood · doi:10.1182/blood-2018-99-116163